CASSIOPE: A prospective noninterventional study of cabozantinib treatment following prior vascular endothelial growth factor (VEGF) -targeted therapy in patients with advanced renal cell carcinoma (aRCC).

被引：0
|
作者：
Staehler, Michael D.
Bigot, Pierre
Barthelemy, Philippe
Hamberg, Paul
Suarez, Cristina
Eymard, Jean-Christophe
Gajate, Pablo
Perrot, Valerie
Qvick, Bryan
Dutailly, Pascale
Procopio, Giuseppe
机构：
[1] Univ Munich, Munich, Germany
[2] Ctr Hosp Univ Angers, Angers, France
[3] Inst Cancerol Strasbourg Europe, Strasbourg, France
[4] Franciscus Gasthuis & Vlietland, Dept Med Oncol, Rotterdam, Netherlands
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Univ Autonoma Barcelona, Inst Oncol, Barcelona, Spain
[7] Inst Jean Godinot, Reims, France
[8] Hosp Univ Ramon y Cajal, Madrid, Spain
[9] Ipsen Pharma, Boulogne, France
[10] Ipsen, Paris, France
[11] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4529
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Expression of vascular endothelial growth factor (VEGF) and activated vascular endothelial growth factor receptors (VEGFR) in renal cell carcinoma
    Ha, Byeong Keun
    Park, Moonja Chung
    [J]. MODERN PATHOLOGY, 2006, 19 : 82 - 82
  • [22] Controversies in renal cell carcinoma: Treatment choice after progression on vascular endothelial growth factor-targeted therapy
    Calvo, Emiliano
    Gruenwald, Viktor
    Bellmunt, Joaquim
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (07) : 1321 - 1329
  • [23] Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma
    Rini, BI
    Small, EJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) : 1028 - 1043
  • [24] Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Therapy
    Golshayan, Ali Reza
    George, Saby
    Heng, Daniel Y.
    Elson, Paul
    Wood, Laura S.
    Mekhail, Tarek M.
    Garcia, Jorge A.
    Aydin, Hakan
    Zhou, Ming
    Bukowski, Ronald M.
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 235 - 241
  • [25] Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor-Targeted Therapy for Renal Cell Carcinoma
    Winer, Andrew G.
    Motzer, Robert J.
    Hakimi, A. Ari
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (01) : 95 - +
  • [26] Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to bone
    Vrdoljak, Eduard
    Rini, Brian
    Schmidinger, Manuela
    Omrcen, Tomislav
    Torday, Laszlo
    Szczylik, Cezary
    Sella, Avishay
    [J]. ANTI-CANCER DRUGS, 2013, 24 (05) : 431 - 440
  • [27] Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas
    Roskoski, Robert, Jr.
    [J]. PHARMACOLOGICAL RESEARCH, 2017, 120 : 116 - 132
  • [28] An observational multicenter French study on unanswered questions in patients with advanced renal cell carcinoma (aRCC) treated with cabozantinib: OCTOPUS
    Thibault, Constance
    Mourey, Loic
    Pasquier, David
    Bernhard, Jean-Christophe
    Boissier, Marion
    Perrot, Valerie
    Albiges, Laurence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 430 - 430
  • [29] Renal cell carcinoma (RCC) primary tumor shrinkage on vascular endothelial growth factor (VEGF)-targeted therapy (TT): A pooled analysis.
    Bosse, Dominick
    Lin, Xun
    Simantov, Ronit
    Lalani, Aly-Khan A.
    Derweesh, Ithaar
    Chang, Steven Lee
    Choueiri, Toni K.
    McKay, Rana R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [30] TUMOUR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS (VEGFR) POLYMORPHISMS AND CLINICAL OUTCOME IN ADVANCED RENAL CELL CARCINOMA PATIENTS RECEIVING FIRST LINE SUNITINIB
    Bianconi, M.
    Scartozzi, M.
    Faloppi, L.
    Loretelli, C.
    Burattini, L.
    Bittoni, A.
    Del Prete, M.
    Giampieri, R.
    Montironi, R.
    Cascinu, S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 274 - 274
12345